Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Senior Subordinated Secured Convertible Note
Preferred Stock
Convertible Preferred Stock
Common Stock
Common Stock
Class A and Class B Common Stock
Common Stock
Class A and Class B Common Stock
Senior Subordinated Secured Convertible Note
Additional Paid-in Capital
Additional Paid-in Capital
Senior Subordinated Secured Convertible Note
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2020     102,408 99,002 0       (13,376)    
Beginning balance at Jan. 31, 2020 $ (22,351)   $ 245,970 $ 3 $ 0   $ 50,117   $ (17,957) $ (988) $ (299,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)     19,902                
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 191,752   $ 191,752                
Stock-based compensation - equity classified awards 32,047           32,047        
Exercise of stock options (in shares)       8,228              
Exercise of stock options and release of vested restricted stock units 13,375           13,375        
Issuance of common stock to a third party (in shares)       1,014              
Issuance of common stock to a third party 5,000           5,000        
Issuance of common stock warrants 7,639           7,639        
Other comprehensive income (loss) 1,109                 1,109  
Net loss (27,166)                   (27,166)
Ending balance (in shares) at Oct. 31, 2020     122,310 108,244 0       (13,376)    
Ending balance at Oct. 31, 2020 201,405   $ 437,722 $ 3 $ 0   108,178   $ (17,957) 121 (326,662)
Beginning balance (in shares) at Jul. 31, 2020     102,408 101,554 0       (13,376)    
Beginning balance at Jul. 31, 2020 (14,516)   $ 245,970 $ 3 $ 0   65,464   $ (17,957) (302) (307,694)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)     19,902                
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 191,752   $ 191,752                
Stock-based compensation - equity classified awards 23,056           23,056        
Exercise of stock options (in shares)       6,690              
Exercise of stock options and release of vested restricted stock units 12,019           12,019        
Issuance of common stock warrants 7,639           7,639        
Other comprehensive income (loss) 423                 423  
Net loss (18,968)                   (18,968)
Ending balance (in shares) at Oct. 31, 2020     122,310 108,244 0       (13,376)    
Ending balance at Oct. 31, 2020 201,405   $ 437,722 $ 3 $ 0   108,178   $ (17,957) 121 (326,662)
Beginning balance (in shares) at Jan. 31, 2021     120,903 109,587 0       (14,131)    
Beginning balance at Jan. 31, 2021 182,733   $ 424,992 $ 4 $ 0   122,061   $ (23,831) 787 (341,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of class A common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)         18,288            
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 275,973           275,973        
Conversion of convertible preferred stock and senior subordinated secured convertible notes (in shares)     (120,903)   120,903 9,694          
Conversion of convertible preferred stock and senior subordinated secured convertible notes 0 $ 82,114 $ (424,992)   $ 4   424,988 $ 82,114      
Stock-based compensation - equity classified awards 37,668           37,668        
Reclassification of common stock to class B common stock (in shares)       (117,176) 117,176            
Reclassification of common stock to Class B common stock 0     $ (4) $ 4            
Exercise of stock options and release of vested restricted stock units (in shares)       7,589 1,454            
Exercise of stock options and release of vested restricted stock units $ 17,893           17,893        
Exercise of stock options (in shares) 8,882                    
Net exercise of common stock warrants (in shares)         230            
Issuance of common stock under deferred stock compensation plan (in shares)         1,770            
Other comprehensive income (loss) $ (792)                 (792)  
Net loss (77,175)                   (77,175)
Ending balance (in shares) at Oct. 31, 2021     0 0 269,515       (14,131)    
Ending balance at Oct. 31, 2021 518,414   $ 0 $ 0 $ 8   960,697   $ (23,831) (5) (418,455)
Beginning balance (in shares) at Jul. 31, 2021     0 0 269,029       (14,131)    
Beginning balance at Jul. 31, 2021 533,984   $ 0 $ 0 $ 8   947,041   $ (23,831) (10) (389,224)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of Class A common stock upon initial public offering, net of underwriting discounts and issuance costs 19           19        
Stock-based compensation - equity classified awards 12,403           12,403        
Exercise of stock options and release of vested restricted stock units (in shares)         486            
Exercise of stock options and release of vested restricted stock units 1,234           1,234        
Other comprehensive income (loss) 5                 5  
Net loss (29,231)                   (29,231)
Ending balance (in shares) at Oct. 31, 2021     0 0 269,515       (14,131)    
Ending balance at Oct. 31, 2021 $ 518,414   $ 0 $ 0 $ 8   $ 960,697   $ (23,831) $ (5) $ (418,455)